Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
AstraZeneca: Berenberg remains Buy with a price target reduced from GBp 12,000 to GBp 11,800.
Blackrock: Credit Suisse initiated coverage with a recommendation of neutral. PT down 7.1% to $540.
Global Payments: Morgan Stanley lowers price target to $128 from $141, maintains equal-weight rating.
Intel: DA Davidson cuts price target to $32 from $41, neutral rating kept.
Lockheed Martin: Baird upgrades to outperform from neutral. PT up 19% to $513.
Marston's: HSBC upgrades from sell to hold targeting GBp 40.
Netflix: KGI Securities raised its recommendation to outperform from neutral. PT up 37% to $330.
PepsiCo: Bernstein raises price target to $172 from $166, maintains underperform rating.
Polaris: Citi analyst James Hardiman downgrades to neutral from buy. PT up 2.2% to $101.
Roku: Morgan Stanley lowers price target to $50 from $55, maintains underweight rating.
Schwab: Credit Suisse initiated coverage with a recommendation of outperform. PT up 17% to $80.
Signature Bank: Keefe, Bruyette & Woods downgrades to market perform from outperform. PT rises 18% to $185.
State Street Corp: DA Davidson lowers price target to $87 from $96, maintains buy rating.
The Goldman Sachs Group: Keefe Bruyette & Woods raises price target to $438 from $429, maintains outperform rating.
Truist Financial: Evercore ISI downgrades to inline from outperform. PT up 8.4% to $47.